Sintlife

Mouldable Bone Substitute

Sintlife

SINTlife Putty is a synthetic fully resorbable graft made of magnesium substituted hydroxyapatite nano-crystals.

Mimicking nature, magnesium ions are introduced into apatite crystal cells replicating the same positioning and composition as found in the mineral phase of human bone, making this the obvious formula for bone regeneration.

Sintlife

TECHNICAL SPECIFICATIONS

Mg substituted A
Mg substituted B
Mg substituted C
Mg substituted D

Mg-substituted apatite: just as nature designed it

It has been demonstrated that the presence of Mg2+ enables the hydroxyapatite crystal cell structure to become unstable and biologically active, promoting rapid cell-mediated material resorption, bone formation and remodelling.

In addition, Mg2+ substituted apatite displays improved surface properties: the biomaterial effectively interacts with water molecules* to rapidly capture the key proteins involved in osteogenesis.

*Bertinetti et al. Langmuir (2009)

Synchronized A
Synchronized B
Synchronized C

Synchronized process: material resorption and new bone formation

SINTlife is a unique material that interacts with bone-forming cells and promotes deposition of new bone tissue. Thanks to its specific biomimetic chemical composition, nano-structure and surface properties, SINTlife is remodelled and resorbed by cellular action over a period of 6-18 months, allowing for sufficient biostimulative scaffold to remain during the formation and maturation of new bone.

During the remodelling phase, osteoclastic resorption and osteoblastic osteogenenetic activities are seen around the remaining SINTlife particles*, up to a complete bone regeneration. As a result, SINTlife leads to a physiological, rapid and effective repair.

*Landi et al., J. Mater Sci: Mater Med (2008)

Sintlife

INDICATIONS

Clinical applications

SINTlife is designed for use in a broad range of procedures, such as:

Scheletro Sintlife
Combined A
Combined B
Combined C
Combined D

SINTlife may be combined with autologous bone, blood, bone marrow or growth factors.

SINTlife is not intended to modify or replace standard procedures for the treatment of bone defects, but for filling bony voids or gaps of the skeletal system, that are not intrinsic to the stability of the bony structure. It must be used with appropriate stabilising hardware.

Sintlife

SHAPES AND SIZES

SINTlife Spine is available with the following codes:

Sintlife spine
Sintlife spine
Code Description Quantity
PFS015057-08-00 Putty (1,5 cc syringe) 1
PFS015057-04-00 Putty (2,5 cc syringe) 1
PFS015057-05-00 Putty (5 cc syringe) 1

Sintlife Ortho is available with the following codes:

Sintlife Ortho (*provided with cannula)
Sintlife Ortho (*provided with cannula)
Code Description Quantity
PFS015056-01-00 Putty (1 cc syringe) 1
PFS015056-02-00 Putty (2.5 cc syringe)* 1
PFS015056-00-00 Putty (5 cc syringe)* 1
PFS015056-05-00 Putty (10 cc syringe)* 1
Explore resources by product

CLINICAL STUDIES

Clinical paper
12/2023 - A.Barbanera et al. Observational, spontaneus clinical study on the performance and safety of the magnesium-hydroxyapatite bone graft substitute SintLife in spine interbody fusion. » Learn more Download Download PDF
Product: Sintlife
Keyword: Performance Safety
Clinical paper
04/2023 - B. Zanotti et al. The benefit of antibiotic-combined Mg-hydroxyapatite bone graft substitute over autologous bone for surgical site infection prevention in posterolateral spinal fusion: a retrospective cohort study. » Learn more Download Download PDF
Product: Sintlife
Keyword: Performance Safety
Clinical paper
11/2022 - C. Griffoni et al. Ceramic bone graft substitute (Mg-HA) in spinal fusion: a prospective pilot study. » Learn more Download Download PDF
Product: Sintlife
Keyword: Performance Safety
Clinical paper
01/2021 - V. Cioffi et al. Anterior cervical fusion using magnesium-enriched hydroxyapatite: a two-year follow-up in 75 cases. » Learn more Download Download PDF
Product: Sintlife
Keyword: Performance Safety
Clinical paper
01/2021 - B. Zanotti et al. Efficacy and safety of the magnesium-hydroxyapatite bone graft substitute in postero-lateral spinal fusion: observational, spontaneous clinical study. » Learn more Download Download PDF
Product: Sintlife
Keyword: Performance Safety
Clinical paper
10/2015 - G. Barbanti Brodano et al. A Post-Market Surveillance Analysis of the safety of hydroxyapatite-derived products as bone graft extenders or substitutes for spine fusion. » Learn more
Product: Engipore
Keyword: Safety Spine Fusion
Pre-clinical paper
05/2014 - G. Barbanti Brodano et al. Hydroxyapatite-Based Biomaterials vs. Autologous Bone Graft in Spinal Fusion: An in Vivo Animal Study. » Learn more
Product: Sintlife
Keyword: Osteointegration
Clinical paper
09/2011 - D. Dallari et al. A prospective, randomised, controlled trial using a Mg-hydroxyapatite - demineralized bone matrix nanocomposite in tibial osteotomy. » Learn more
Product: Sintlife
Keyword: Performance Safety
Pre-clinical paper
01/2011 - E. Pola et al. Bioplasty for vertebral fractures: preliminary results of a pre-clinical study on goats using autologous modified skin fibroblast. » Learn more
Product: Sintlife
Keyword: Osteointegration